Language selection

Government of Canada / Gouvernement du Canada

Search

AMVAD adjuvant for mucosal vaccines (L-11561) .: NR16-173/2017E-PDF

“The NRC has developed a novel archaeal polar lipid mucosal vaccine adjuvant and delivery (AMVAD) platform capable of generating mucosal and systemic immune responses against a wide range of pathogens that infect mucosal surfaces or use them to gain entry to the body”--Highlights, p. [1].

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.847520&sl=0

Publication information
Department/Agency
  • National Research Council Canada.
TitleAMVAD adjuvant for mucosal vaccines (L-11561) .
Publication typeMonograph
Language[English]
Other language editions[French]
FormatDigital text
Electronic document
Note(s)
  • Issued also in French under title: Adjuvant AMVAD pour vaccins muqueux (L-11561).
  • Caption title.
  • "January 2017."
  • Issued also in print format.
Publishing information
  • [Ottawa] : National Research Council Canada, [2018]
Description[2] p. : ill.
ISBN9780660239385
Catalogue number
  • NR16-173/2017E-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: